Multitargeted Kinase Inhibitor JNJ-26483327
Cancer Terms ->
Drugs and Chemicals ->
Pharmacologic Substance ->
Enzyme Inhibitor ->
Protein Kinase Inhibitor ->
Tyrosine Kinase Inhibitor -> Multitargeted Kinase Inhibitor JNJ-26483327
Multitargeted Kinase Inhibitor JNJ-26483327 Definition
An orally bioavailable, small-molecule, multitargeted reversible tyrosine kinase inhibitor with potential antineoplastic activity. Multitargeted tyrosine kinase inhibitor JNJ-26483327 binds to and inhibits several members of the epidermal growth factor receptor (EGFR) family, including EGFR, HER2 and HER4; Src family kinases (Lyn, Yes, Fyn, Lck and Src); and vascular endothelial growth factor receptor type 3 (VEGFR3). By inhibiting several different signaling molecules that play crucial roles at various stages in tumorigenesis, this agent may inhibit tumor growth, invasion, migration and metastasis. In addition, JNJ-26483327 crosses the blood-brain barrier (BBB).
Multitargeted Kinase Inhibitor JNJ-26483327 Synonyms
Multitargeted Tyrosine Kinase Inhibitor JNJ-26483327, JNJ-26483327, TKI JNJ-26483327
Terms in Multitargeted Kinase Inhibitor JNJ-26483327 category
Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods
No reproduction or republication permitted.